Johnson & Johnson (NYSE: JNJ) announced today that 43 presentations showcasing the Company's rheumatology pipeline and portfolio will be featured at the American College of Rheumatology (ACR) 2024 ...

Dr Judy Chou, CEO, President and Board Member of AltruBio, Inc, explains how agonist antibodies show potential as a novel therapeutic approach in immunological diseases.

Ulcerative colitis (UC) is a chronic gut inflammatory condition affecting the colon in humans. This study uses human samples as well as a mouse model of colitis induced by a chemical, DSS, to ...

A new study from UCSF conducted on mice reveals that the diet boosts levels of anti-inflammatory compounds. Scientists have ...

Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this.

This study uncovers the ketogenic diet's effects on the microbiome, revealing its potential to mitigate autoimmune diseases through metabolic pathways.

Tumour Necrosis Factor TNF is crucial for defence but can drive chronic inflammation linked to arthritis and autoimmune diseases when overproduced ...

A certain vitamin deficiency could trigger autoimmune conditions. Researchers at McGill University in Canada studied mice ...

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...

Many people with rheumatologic diseases try supplements for symptom relief ... Pharmacoepidemiology showed that methotrexate ...

A recent meta-analysis published in JAMA Neurology has revealed that tumor necrosis factor (TNF) inhibitors, widely used in treating autoimmune diseases, may increase the risk of ...